In this issue
Research
Substandard and falsified medicines: global and local efforts to address a growing problemSubscription
Substandard and falsified medicines pose a risk to public health all around the world.
Insight
‘One-size-fits-all’ treatment targets harm frail older patients with diabetesSubscription
HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.
CPD article
Stevens–Johnson syndrome and toxic epidermal necrolysisSubscription
Practical guidelines for the treatment and management of Stevens–Johnson syndrome and toxic epidermal necrolysis, rare but life-threatening conditions that are normally caused by drugs or infections.
